Surgical strategy for ischemic mitral regurgitation adopting subvalvular and ventricular procedures

Satoru Wakasa1, Yasushige Shingu, Tomonori Ooka

  • 1Department of Cardiovascular and Thoracic Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan.

Abstract

Insights

Surgical strategies combining annuloplasty with additional procedures improve outcomes for ischemic mitral regurgitation (MR) by addressing left ventricular (LV) remodeling and tethering.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery
  • Heart Valve Repair

Background:

  • Left ventricular (LV) remodeling and mitral valve tethering negatively impact surgical outcomes for ischemic mitral regurgitation (MR).
  • Standard annuloplasty alone may be insufficient for patients with advanced LV disease.

Purpose of the Study:

  • To evaluate the efficacy of a staged surgical approach for ischemic MR, incorporating additional procedures to address LV remodeling and tethering.
  • To compare outcomes of annuloplasty alone versus combined strategies.

Main Methods:

  • A retrospective study of 90 patients undergoing surgical repair for ischemic MR between 1999 and 2013.
  • Patients were divided into three stages: annuloplasty alone (Stage 1), annuloplasty with papillary muscle approximation (PMA) (Stage 2), and annuloplasty with PMA and left ventriculoplasty (Stage 3).

Main Results:

  • Preoperative differences in New York Heart Association (NYHA) class, LV end-diastolic diameter, and LV ejection fraction were significant across stages.
  • Despite baseline differences, mitral regurgitation grades remained comparable postoperatively.
  • Cardiac-related survival and freedom from reoperation rates were similar across all three surgical stages.

Conclusions:

  • Additional submitral and ventricular procedures, including PMA and ventriculoplasty, effectively compensate for impaired outcomes associated with annuloplasty alone.
  • These combined strategies offer a viable solution for ischemic MR in patients with significant LV remodeling and tethering.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
484
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
617
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
555
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
562
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.3K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.2K